Pharmaceutical maker Shionogi tapping AI to speed drug development - (Nikkei Asian Review via NewsPoints Desk)

  • Shionogi has started to recruit employees with information technology skills to fuel its drug development efforts, Nikkei Asian Review reported Friday.

  • Director Takuko Sawada acknowledged that Takeda has been late in digitising its drug development efforts.

  • The drugmaker has hired IT firm Accenture in an effort to reduce daily management costs and use artificial intelligence (AI) to speed new drug development.

  • Multinational firms such as Johnson & Johnson and Pfizer have already invested resources into development of their own software and network systems for AI-based drug discovery.

  • Credit Suisse Securities analyst Fumiyoshi Sakai noted that by outsourcing its core AI system, "the company can cut its costs and channel those resources into the nurturing of personnel for tasks like AI drug discovery."

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.